| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
36,747 |
26,647 |
$5.74M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14,450 |
11,098 |
$3.50M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
14,450 |
10,752 |
$1.12M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
782 |
642 |
$317K |
| 80053 |
Comprehensive metabolic panel |
13,243 |
11,702 |
$210K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,278 |
12,574 |
$199K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
528 |
465 |
$175K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,840 |
1,634 |
$81K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,381 |
1,063 |
$78K |
| 71046 |
Radiologic examination, chest; 2 views |
6,108 |
4,902 |
$75K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
73 |
59 |
$68K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
568 |
523 |
$63K |
| 36415 |
Collection of venous blood by venipuncture |
9,888 |
8,643 |
$60K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,206 |
1,041 |
$54K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,197 |
1,802 |
$54K |
| J3490 |
Unclassified drugs |
3,238 |
2,477 |
$49K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
729 |
557 |
$48K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,443 |
1,271 |
$40K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
368 |
249 |
$36K |
| 71045 |
Radiologic examination, chest; single view |
2,213 |
1,698 |
$32K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,090 |
991 |
$31K |
| 70450 |
Computed tomography, head or brain; without contrast material |
935 |
753 |
$27K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,102 |
1,007 |
$26K |
| 83690 |
|
991 |
889 |
$22K |
| 84484 |
|
632 |
537 |
$21K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,200 |
1,050 |
$21K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
760 |
645 |
$19K |
| 81002 |
|
3,402 |
2,943 |
$19K |
| 80061 |
Lipid panel |
752 |
680 |
$18K |
| 0001A |
|
748 |
644 |
$15K |
| 0002A |
|
698 |
610 |
$15K |
| 0012A |
|
750 |
662 |
$14K |
| 73630 |
|
1,116 |
921 |
$14K |
| 94060 |
|
181 |
112 |
$13K |
| 0011A |
|
804 |
719 |
$12K |
| 87631 |
|
178 |
159 |
$12K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
182 |
149 |
$11K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
240 |
218 |
$10K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
327 |
285 |
$10K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
219 |
182 |
$10K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
399 |
354 |
$8K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
509 |
424 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
361 |
337 |
$6K |
| 73562 |
|
999 |
779 |
$6K |
| 83735 |
|
466 |
422 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
361 |
322 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
915 |
800 |
$5K |
| 83605 |
|
259 |
211 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
130 |
107 |
$5K |
| 73610 |
|
682 |
585 |
$4K |
| 72100 |
|
508 |
467 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
130 |
107 |
$4K |
| 95800 |
|
46 |
30 |
$4K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
706 |
648 |
$3K |
| 82728 |
|
133 |
114 |
$3K |
| 59025 |
Fetal non-stress test |
17 |
13 |
$3K |
| 73030 |
|
552 |
445 |
$3K |
| 81001 |
|
1,070 |
1,006 |
$3K |
| 73130 |
|
431 |
363 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
253 |
245 |
$3K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
66 |
24 |
$3K |
| 73110 |
|
396 |
341 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
69 |
54 |
$3K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
93 |
84 |
$2K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
99 |
81 |
$2K |
| 76830 |
Ultrasound, transvaginal |
75 |
68 |
$2K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
37 |
36 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
150 |
137 |
$1K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
399 |
324 |
$1K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
15 |
14 |
$1K |
| 86592 |
|
77 |
74 |
$1K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
46 |
37 |
$1K |
| A0425 |
Ground mileage, per statute mile |
22 |
19 |
$1K |
| 96158 |
|
21 |
17 |
$869.40 |
| 96156 |
|
14 |
14 |
$850.08 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
27 |
26 |
$817.68 |
| 76770 |
|
33 |
28 |
$800.51 |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
13 |
12 |
$797.08 |
| J1790 |
Injection, droperidol, up to 5 mg |
72 |
62 |
$776.57 |
| 83880 |
|
12 |
12 |
$771.36 |
| 86140 |
|
59 |
50 |
$737.17 |
| 94729 |
|
52 |
27 |
$656.24 |
| 71250 |
|
32 |
26 |
$649.72 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
41 |
38 |
$648.82 |
| 85378 |
|
24 |
24 |
$635.62 |
| J2704 |
Injection, propofol, 10 mg |
43 |
40 |
$626.17 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13 |
12 |
$596.91 |
| 97602 |
|
31 |
12 |
$501.34 |
| 84439 |
|
27 |
25 |
$500.84 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
167 |
158 |
$481.92 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12 |
12 |
$405.90 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
53 |
50 |
$361.43 |
| 85379 |
|
13 |
12 |
$346.06 |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
17 |
13 |
$318.96 |
| 86850 |
|
15 |
13 |
$307.84 |
| 73501 |
|
46 |
40 |
$293.21 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
13 |
13 |
$286.09 |
| 86803 |
|
15 |
15 |
$267.09 |
| 72040 |
|
29 |
28 |
$262.35 |
| 87480 |
|
13 |
12 |
$259.15 |
| 84703 |
|
17 |
14 |
$256.56 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
55 |
40 |
$242.18 |
| 82950 |
|
16 |
12 |
$213.19 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
16 |
15 |
$198.32 |
| 93000 |
|
14 |
13 |
$169.55 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
15 |
14 |
$153.72 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
13 |
12 |
$129.32 |
| 90686 |
|
20 |
20 |
$103.53 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
20 |
20 |
$84.72 |
| 73140 |
|
13 |
12 |
$69.61 |
| 77080 |
|
13 |
13 |
$64.92 |
| 0003A |
|
66 |
65 |
$40.00 |
| 81025 |
|
13 |
12 |
$33.18 |
| 0013A |
|
60 |
60 |
$0.00 |
| 3078F |
|
20 |
19 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
108 |
97 |
$0.00 |
| 3008F |
|
19 |
18 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
27 |
15 |
$0.00 |
| 3074F |
|
14 |
14 |
$0.00 |
| 81000 |
|
15 |
13 |
$0.00 |